NSTG News and Press, NanoString Technologies Inc. From 11/27/23

2023-11-27 14:50:33 ET More on NanoString NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript NanoString cut to Neutral at Baird after patent loss to 10x Genomics Biggest stock movers today: Boeing, NanoString, NuScale Power, Chegg and more ...

2023-11-21 17:01:18 ET More on NanoString NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript NanoString cut to Neutral at Baird after patent loss to 10x Genomics Biggest stock movers today: Boeing, NanoString, NuScale Power, Chegg and more ...

2023-11-21 08:20:13 ET More on NanoString NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript Biggest stock movers today: Boeing, NanoString, NuScale Power, Chegg and more NanoString falls as company pulls guidance after patent setback Seeki...

2023-11-20 12:59:05 ET Gainers: Mira Pharmaceuticals ( MIRA ) +58% . YPF ADR ( YPF ) +39% . Altamira Therapeutics Ltd ( CYTO ) +39% . ProKidney Corp ( PROK ) +35% . Soluna Holdings ( SLNH ) +32% . Safety Shot ( SHOT ) +...

2023-11-20 10:04:20 ET More on NanoString NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript NanoString slips after 10x Genomics wins patent infringement case in U.S. NanoString expects Q3 results to top forecasts; reorganizes operations Se...

2023-11-20 10:00:12 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Fortress Biote...

2023-11-20 08:24:45 ET Losers: Syntec Optics Holdings ( OPTX ) -15% . Safe and Green Development Corp ( SGD ) -14% . Plus Therapeutics ( PSTV ) -14% reports new interim reSPECT-GBM phase 2 trial data at the society for NeuroOncology annual meeting. ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17 th verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx® Digital Spatial Profil...

2023-11-17 17:41:34 ET More on 10x Genomics 10x Genomics: Unveiling The Investment Potential 10x Genomics reports mixed Q3 earnings; raises FY23 outlook For further details see: NanoString slips after 10x Genomics wins patent infringement case in U.S.

2023-11-17 05:55:00 ET Summary Biotech sector faces challenges including higher interest rates, inflation, regulatory pressures, and a post-COVID slump. Short interest remains high for some pharmaceutical companies, indicating bearish sentiment. Exchange-traded funds in the bi...